Biological insights from clinical trials and networks

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 5, 2012, Pages 475-476

  Thannickal, Victor J ^a   Hagood, James S ^b  

^a University of Alabama at Birmingham   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CRYOPYRIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PRAVASTATIN; REACTIVE OXYGEN METABOLITE;

AGING; BRONCHIECTASIS; CIGARETTE SMOKING; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EDITORIAL; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG INJURY; MACROPHAGE; MITOCHONDRION; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; TRANSLATIONAL RESEARCH;

ANIMALS; CARRIER PROTEINS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMASOMES; MALE;

EID: 84857844314     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201201-0047ED     Document Type: Editorial

References (10)

1. Xu J-F, Washko G, Nakahira K, Hatabu H, Patel A, Fernandez I, Nishino M, Okajima Y, Yamashiro T, Ross J, et al. Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med 2012;185:547-556.
2. Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Estepar RS, Lynch DA, Brehm JM, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011;364:897-906.
3. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS. The NALP3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 2008;105:9035-9040.
4. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through NALP3 inflammasome sensing of asbestos and silica. Science 2008;320:674-677. (Pubitemid 351928351)
5. Biswas R, Bunderson-Schelvan M, Holian A. Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis. Pulm Med 2011;2011:105707.
6. Riteau N, Gasse P, Fauconnier L, Gombault A, Couegnat M, Fick L, Kanellopoulos J, Quesniaux VF, Marchand-Adam S, Crestani B, et al. Extracellular atp is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med 2010;182:774-783.
7. Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum 2011;63:3563-3574.
8. Zhou Q, Liao JK. Pleiotropic effects of statins: basic research and clinical perspectives. Circ J 2010;74:818-826.
9. Farsaei S, Khalili H, Farboud ES. Potential role of statins on wound healing: review of the literature. Int Wound J (In press)
10. Mawhinney LJ, de Rivero Vaccari JP, Dale GA, Keane RW, Bramlett HM. Heightened inflammasome activation is linked to age-related cognitive impairment in fischer 344 rats. BMC Neurosci 2011;12:123.